BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 8139265)

  • 1. Qualitative and quantitative histopathology in transitional cell carcinomas of the urinary bladder. An international investigation of intra- and interobserver reproducibility.
    Sørensen FB; Sasaki M; Fukuzawa S; Yamabe H; Olsen S; Yoshida O
    Lab Invest; 1994 Feb; 70(2):242-54. PubMed ID: 8139265
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative histopathology in the prognostic evaluation of patients with transitional cell carcinoma of the urinary bladder.
    Sasaki M; Sørensen FB; Fukuzawa S; Yamabe H; Olsen S; Yoshida O
    Cancer; 1993 Oct; 72(8):2470-83. PubMed ID: 8402464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Objective malignancy grading: a review emphasizing unbiased stereology applied to breast tumors.
    Ladekarl M
    APMIS Suppl; 1998; 79():1-34. PubMed ID: 9645191
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urothelial neoplasia of the urinary bladder--comparison of interobserver variability for WHO Classification 1972 with WHO/ISUP Consensus Classification 1998.
    Mamoon N; Iqbal MA; Jamal S; Luqman M
    J Ayub Med Coll Abbottabad; 2006; 18(2):4-8. PubMed ID: 16977804
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reproducibility and prognostic variability of grade and lamina propria invasion in stages Ta, T1 urothelial carcinoma of the bladder.
    Bol MG; Baak JP; Buhr-Wildhagen S; Kruse AJ; Kjellevold KH; Janssen EA; Mestad O; Øgreid P
    J Urol; 2003 Apr; 169(4):1291-4. PubMed ID: 12629345
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multicenter determination of optimal interobserver agreement using the Fuhrman grading system for renal cell carcinoma: Assessment of 241 patients with > 15-year follow-up.
    Lang H; Lindner V; de Fromont M; Molinié V; Letourneux H; Meyer N; Martin M; Jacqmin D
    Cancer; 2005 Feb; 103(3):625-9. PubMed ID: 15611969
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intraobserver and interobserver variability of Fuhrman and modified Fuhrman grading systems for conventional renal cell carcinoma.
    Bektas S; Bahadir B; Kandemir NO; Barut F; Gul AE; Ozdamar SO
    Kaohsiung J Med Sci; 2009 Nov; 25(11):596-600. PubMed ID: 19858038
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validation of World Health Organization/International Society of Urologic Pathology 2004 classification schema for bladder urothelial carcinomas using quantitative nuclear morphometry: identification of predictive features using bootstrap method.
    Kapur U; Antic T; Venkataraman G; Durazo-Arvizu R; Quek MM; Flanigan RC; Wojcik EM
    Urology; 2007 Nov; 70(5):1028-33. PubMed ID: 18068480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Observer variation in interactive computerized morphometry.
    Collan Y; Montironi R; Mariuzzi GM; Torkkeli T; Marinelli F; Pesonen E; Collina G; Kosma VM; Jantunen E; Kosunen O
    Appl Pathol; 1986; 4(1-2):9-14. PubMed ID: 3580196
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of volume weighted mean nuclear volume in predicting the prognosis of patients with primary transitional cell carcinoma of the upper urinary tract: a report of 102 new cases.
    Fujikawa K; Matsui Y; Oka H; Fukuzawa S; Sasaki M; Takeuchi H
    J Urol; 2000 Aug; 164(2):352-5. PubMed ID: 10893583
    [TBL] [Abstract][Full Text] [Related]  

  • 11. p53 expression compared with other prognostic factors in OMS grade-I stage-Ta transitional cell carcinoma of the bladder.
    Casetta G; Gontero P; Russo R; Pacchioni D; Tizzani A
    Eur Urol; 1997; 32(2):229-36. PubMed ID: 9286659
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unbiased stereologic techniques for practical use in diagnostic histopathology.
    Sørensen FB
    Pathologica; 1995 Jun; 87(3):263-78. PubMed ID: 8570287
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nomograms including nuclear matrix protein 22 for prediction of disease recurrence and progression in patients with Ta, T1 or CIS transitional cell carcinoma of the bladder.
    Shariat SF; Zippe C; Lüdecke G; Boman H; Sanchez-Carbayo M; Casella R; Mian C; Friedrich MG; Eissa S; Akaza H; Sawczuk I; Serretta V; Huland H; Hedelin H; Rupesh R; Miyanaga N; Sagalowsky AI; Wians F; Roehrborn CG; Lotan Y; Perrotte P; Benayoun S; Marberger MJ; Karakiewicz PI
    J Urol; 2005 May; 173(5):1518-25. PubMed ID: 15821471
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The value of DNA cytometry in transitional cell carcinoma of the urinary bladder.
    Nenning H; Rassler J; Minh DH; Stolzenburg JU
    Gen Diagn Pathol; 1997 Dec; 143(4):231-6. PubMed ID: 9489956
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The reproducibility of histological parameters employed in the novel binary grading systems of endometrial cancer.
    Gemer O; Uriev L; Voldarsky M; Gdalevich M; Ben-Dor D; Barak F; Anteby EY; Lavie O
    Eur J Surg Oncol; 2009 Mar; 35(3):247-51. PubMed ID: 18775628
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Results of radical cystectomy for management of invasive bladder cancer with special reference to prognostic factors and quality of life depending on the type of urinary diversion].
    Słojewski M
    Ann Acad Med Stetin; 2000; 46():217-29. PubMed ID: 11712306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NTP Toxicology and Carcinogenesis Studies of 1-Amino-2,4-Dibromoanthraquinone (CAS No. 81-49-2) in F344/N Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1996 Aug; 383():1-370. PubMed ID: 12692653
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathologic features of bladder tumors after nephroureterectomy or segmental ureterectomy for upper urinary tract transitional cell carcinoma.
    Raman JD; Sosa RE; Vaughan ED; Scherr DS
    Urology; 2007 Feb; 69(2):251-4. PubMed ID: 17320658
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasmacytoid transitional cell carcinoma of urinary bladder: a clinicopathologic study of 9 cases.
    Ro JY; Shen SS; Lee HI; Hong EK; Lee YH; Cho NH; Jung SJ; Choi YJ; Ayala AG
    Am J Surg Pathol; 2008 May; 32(5):752-7. PubMed ID: 18379419
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical significance of stereological estimation of mean nuclear volume in human bladder carcinoma--further analysis of nuclear morphometric variables].
    Fukuzawa S; Hashimura T; Horii Y; Yoshida O; Sasaki M
    Hinyokika Kiyo; 1992 Dec; 38(12):1361-8. PubMed ID: 1288224
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.